查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1193342

椎体成形术和骨盆成形术市场：最终用户（医院、门诊手术中心）的副产品（椎体成形术、椎体成形术）：2021-2031 年全球机会分析和行业预测

Vertebroplasty and Kyphoplasty Market By Product (Kyphoplasty, Vertebroplasty), By End User (Hospitals, Ambulatory Surgical Centers): Global Opportunity Analysis and Industry Forecast, 2021-2031
出版日期: | 出版商: Allied Market Research | 英文 183 Pages | 商品交期: 2-3个工作天内

价格

全球椎体成形术和骨盆成形术市场在 2021 年价值 7.571 亿美元，到 2031 年达到 13.081 亿美元，2022-2031 年预计将以 5.6% 的复合年增长率增长

椎体成形术和骨盆成形术是用于治疗脊髓椎体压缩性骨折的微创手术技术。 椎体成形术是一种将特殊骨水泥注射到骨折的椎体中以帮助缓解脊髓疼痛并恢復身体活动能力的技术。 在椎体成形术中，一种称为聚甲基丙烯酸甲酯的骨水泥通过空心针注射到骨折的骨头中。 另一方面，椎体成形术也涉及将一种特殊的骨水泥注入患者的脊柱，但它也被称为球囊成形术，因为它采取了用球囊状装置创造治疗空间的步骤。 枕骨成形术也被推荐用于治疗椎骨骨折，例如被癌症损坏的椎体。 进行这些手术是为了停止脊柱骨折引起的疼痛，稳定骨骼，并恢復因压缩性骨折而丢失的椎体高度。

脊椎骨折发病率上升是市场增长的主要驱动力。 根据美国骨科医师学会 2021 年 11 月发布的数据，美国每年估计有 150 万例脊柱骨折发生，这种情况主要与骨质疏鬆症、跌倒、运动损伤、外伤等引起车祸。 这种情况可以通过治疗和数月的牙套治愈，但严重的椎骨骨折需要手术干预。

此外，椎体成形术和骨盆成形术是治疗严重骨折的方法。 椎体骨折发病率的上升进一步增加了对椎体成形术和骨盆成形术等治疗程序的需求，从而推动了市场的增长。

内容

第一章介绍

第 2 章执行摘要

第 3 章市场概述

  • 市场定义和范围
  • 主要发现
    • 主要投资领域
  • 波特的五力分析
  • 主要公司的定位
  • 市场动态
    • 司机
    • 约束因素
    • 机会
  • COVID-19 影响分析

第 4 章椎体成形术和骨盆成形术市场：按产品分类

  • 概览
    • 市场规模和预测
  • Kaifoplasty
    • 主要市场趋势、增长因素和机遇
    • 市场规模和预测：按地区
    • 市场份额分析：按国家/地区分类
  • 椎体成形术
    • 主要市场趋势、增长因素和机遇
    • 市场规模和预测：按地区
    • 市场份额分析：按国家/地区分类

第 5 章椎体成形术和骨盆成形术市场：按最终用户分类

  • 概览
    • 市场规模和预测
  • 医院
    • 主要市场趋势、增长动力和机遇
    • 市场规模和预测：按地区
    • 市场份额分析：按国家/地区分类
  • 门诊手术中心
    • 主要市场趋势、增长因素和机遇
    • 市场规模和预测：按地区
    • 市场份额分析：按国家/地区分类

第 6 章椎体成形术和骨盆成形术市场：按地区

  • 概览
    • 市场规模和预测
  • 北美
    • 主要趋势和机会
    • 北美市场规模和预测：按产品
    • 北美市场规模和预测：按最终用户分类
    • 北美市场规模和预测：按国家/地区分类
      • 美国
      • 加拿大
      • 墨西哥
  • 欧洲
    • 主要趋势和机会
    • 欧洲市场规模和预测：按产品
    • 欧洲市场规模和预测：按最终用户分类
    • 欧洲市场规模和预测：按国家/地区分类
      • 德国
      • 法国
      • 英国
      • 意大利
      • 西班牙
      • 其他欧洲地区
  • 亚太地区
    • 主要趋势和机会
    • 亚太市场规模和预测：按产品
    • 亚太市场规模和预测：按最终用户分类
    • 亚太地区的市场规模和预测：按国家/地区分类
      • 日本
      • 中国
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
  • 拉美
    • 主要趋势和机会
    • LAMEA 市场规模和预测：按产品
    • LAMEA 市场规模和预测：按最终用户分类
    • LAMEA 市场规模和预测：按国家/地区分类
      • 巴西
      • 沙特阿拉伯
      • 南非
      • LAMEA 的其余部分

第七章商业条件

  • 简介
  • 关键成功策略
  • 10 家主要公司的产品映射
  • 比赛仪表板
  • 竞争热图
  • 主要发展

第八章公司简介

  • Johnson and Johnson（DePuy Synthes）
  • Medtronic plc
  • Globus Medical Inc
  • Halma plc
  • Zavation LLC
  • BPB MEDICA-BIOPSYBELL
  • Merit Medical Systems Inc.
  • Seawon Meditech
  • Joimax GmbH
  • Stryker Corporation
Product Code: A10444

The global vertebroplasty and kyphoplasty market was valued at $757.1 million in 2021, and is projected to reach $1,308.1 million by 2031, registering a CAGR of 5.6% from 2022 to 2031.Vertebroplasty and kyphoplasty are minimally invasive surgical techniques, used for the treatment of vertebral compression factures in the spinal cord. Vertebroplasty is a technique, which includes the injection of special cement into the fractured vertebra that provides relief from spinal pain and helps restore the mobility of body. In vertebroplasty, bone cement, also named as polymethyl-methacrylate, is injected through the hollow needle into the fractured bone. On the other hand, kyphoplasty also involves the injection of special cement into the patients' vertebrae, but with an additional step by creating space for the treatment with a balloon-like device, which is also known as balloon kyphoplasty. In addition, kyphoplasty is recommended for the treatment of cancer-damaged vertebrae and other spinal fractures. These surgical procedures are used to stop the pain caused by a spinal fracture, to stabilize the bone and to restore the loss of vertebral body height due to the compression fracture.

Rise in number of vertebral column factures is the major driving factor for the growth of the market. According to the data published by American Academy of Orthopedic Surgeons in November 2021, there are an estimated 1.5 million vertebral column fracture cases each year in the U.S. This condition mainly occurs due to osteoporosis and traumas like falls, sports injuries or car accidents, and others. Although, the condition can be treated through therapies and by wearing braces for few months, but severe spinal fractures need to be treated through surgical procedure. Furthermore, vertebroplasty and kyphoplasty techniques are

severe fractures. Rise in incidence of vertebral column fractures further demands for treatment procedures such as vertebroplasty and kyphoplasty, thus, propelling the growth of the market.

In addition, rise in advancements in the healthcare sector is also driving the market growth. For instance, the development of OsseoFlex System, which includes an expandable titanium mesh cage, is used in the treatment of osteoporotic vertebral fractures (OVCFs). This technique is used to prevent kyphotic deformity by compacting the surrounding trabecular bone. Further, the height of the fractured vertebra is restored by injection of special cement and by the compaction of the trabecular bone by the titanium mesh cage. In addition, less cement is required in such technique than that of the percutaneous kyphoplasty. Thus, more such advancements in the field of vertebroplasty and kyphoplasty augment the growth of the market during the forecast period.

Also, rise in adoption of minimally invasive surgeries around the globe, is driving the market growth. As vertebroplasty and kyphoplasty are well-known minimally invasive surgery techniques, nowadays there is witnessed rise in their adoption for the treatment of vertebral compression fractures. The advantages offered by minimally invasive surgeries, such as less pain, faster recovery after an operation, earlier return to work, and better results are leading to rise in adoption of this technique by the healthcare provider and also the patients, which further leads to the expansion of the market.

Furthermore, factors such as increase in geriatric population, rise in incidence of vertebral fractures, growing healthcare facilities, increase in demand for technically advanced products, presence of major market manufacturers along with rising technological advancements in vertebroplasty and kyphoplasty, and increasing developments in the medical devices industry are driving the growth of the vertebroplasty and kyphoplasty market. Although many factors are diving the growth of the market, the high cost related to these advanced

surgical techniques along with minor risk associated with these surgeries is causing hindrance to the growth of the market. In addition, the major opportunities available for the vertebroplasty and kyphoplasty market include medical tourism due to high cost of surgeries, growth opportunity in emerging markets, and technological advancement in product associated with the management of vertebral fractures.

The vertebroplasty and kyphoplasty market is studied on the basis of product, end user, and region. By product, the market is segmented into kyphoplasty and vertebroplasty. By end user, it is classified into hospitals and ambulatory surgical centers. Region-wise, the market has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The major companies profiled in this report include, BPB Medica - Biopsybell, Johnson & Johnson (DePuy Synthes), Globus Medical Inc., Halma plc. (IZI Medical Products), Joimax GmbH, Medtronic plc., Merit Medical Systems Inc., Seawon Meditech, Stryker Corporation, and Zavation.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the vertebroplasty and kyphoplasty market analysis from 2021 to 2031 to identify the prevailing vertebroplasty and kyphoplasty market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the vertebroplasty and kyphoplasty market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global vertebroplasty and kyphoplasty market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Product

  • Kyphoplasty
  • Vertebroplasty

By End User

  • Hospitals
  • Ambulatory Surgical Centers

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
  • Key Market Players
    • Johnson and Johnson (DePuy Synthes)
    • Medtronic plc
    • Globus Medical Inc
    • Halma plc
    • Zavation LLC
    • BPB MEDICA - BIOPSYBELL
    • Merit Medical Systems Inc.
    • Seawon Meditech
    • Joimax GmbH
    • Stryker Corporation

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
  • 1.3.Key benefits to the stakeholders
  • 1.4.Research Methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning
  • 3.5.Market dynamics
    • 3.5.1.Drivers
    • 3.5.2.Restraints
    • 3.5.3.Opportunities
  • 3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT

  • 4.1 Overview
    • 4.1.1 Market size and forecast
  • 4.2 Kyphoplasty
    • 4.2.1 Key market trends, growth factors and opportunities
    • 4.2.2 Market size and forecast, by region
    • 4.2.3 Market share analysis by country
  • 4.3 Vertebroplasty
    • 4.3.1 Key market trends, growth factors and opportunities
    • 4.3.2 Market size and forecast, by region
    • 4.3.3 Market share analysis by country

CHAPTER 5: VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER

  • 5.1 Overview
    • 5.1.1 Market size and forecast
  • 5.2 Hospitals
    • 5.2.1 Key market trends, growth factors and opportunities
    • 5.2.2 Market size and forecast, by region
    • 5.2.3 Market share analysis by country
  • 5.3 Ambulatory Surgical Centers
    • 5.3.1 Key market trends, growth factors and opportunities
    • 5.3.2 Market size and forecast, by region
    • 5.3.3 Market share analysis by country

CHAPTER 6: VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY REGION

  • 6.1 Overview
    • 6.1.1 Market size and forecast
  • 6.2 North America
    • 6.2.1 Key trends and opportunities
    • 6.2.2 North America Market size and forecast, by Product
    • 6.2.3 North America Market size and forecast, by End User
    • 6.2.4 North America Market size and forecast, by country
      • 6.2.4.1 U.S.
      • 6.2.4.1.1 Key market trends, growth factors and opportunities
      • 6.2.4.1.2 Market size and forecast, by Product
      • 6.2.4.1.3 Market size and forecast, by End User
      • 6.2.4.2 Canada
      • 6.2.4.2.1 Key market trends, growth factors and opportunities
      • 6.2.4.2.2 Market size and forecast, by Product
      • 6.2.4.2.3 Market size and forecast, by End User
      • 6.2.4.3 Mexico
      • 6.2.4.3.1 Key market trends, growth factors and opportunities
      • 6.2.4.3.2 Market size and forecast, by Product
      • 6.2.4.3.3 Market size and forecast, by End User
  • 6.3 Europe
    • 6.3.1 Key trends and opportunities
    • 6.3.2 Europe Market size and forecast, by Product
    • 6.3.3 Europe Market size and forecast, by End User
    • 6.3.4 Europe Market size and forecast, by country
      • 6.3.4.1 Germany
      • 6.3.4.1.1 Key market trends, growth factors and opportunities
      • 6.3.4.1.2 Market size and forecast, by Product
      • 6.3.4.1.3 Market size and forecast, by End User
      • 6.3.4.2 France
      • 6.3.4.2.1 Key market trends, growth factors and opportunities
      • 6.3.4.2.2 Market size and forecast, by Product
      • 6.3.4.2.3 Market size and forecast, by End User
      • 6.3.4.3 UK
      • 6.3.4.3.1 Key market trends, growth factors and opportunities
      • 6.3.4.3.2 Market size and forecast, by Product
      • 6.3.4.3.3 Market size and forecast, by End User
      • 6.3.4.4 Italy
      • 6.3.4.4.1 Key market trends, growth factors and opportunities
      • 6.3.4.4.2 Market size and forecast, by Product
      • 6.3.4.4.3 Market size and forecast, by End User
      • 6.3.4.5 Spain
      • 6.3.4.5.1 Key market trends, growth factors and opportunities
      • 6.3.4.5.2 Market size and forecast, by Product
      • 6.3.4.5.3 Market size and forecast, by End User
      • 6.3.4.6 Rest of Europe
      • 6.3.4.6.1 Key market trends, growth factors and opportunities
      • 6.3.4.6.2 Market size and forecast, by Product
      • 6.3.4.6.3 Market size and forecast, by End User
  • 6.4 Asia-Pacific
    • 6.4.1 Key trends and opportunities
    • 6.4.2 Asia-Pacific Market size and forecast, by Product
    • 6.4.3 Asia-Pacific Market size and forecast, by End User
    • 6.4.4 Asia-Pacific Market size and forecast, by country
      • 6.4.4.1 Japan
      • 6.4.4.1.1 Key market trends, growth factors and opportunities
      • 6.4.4.1.2 Market size and forecast, by Product
      • 6.4.4.1.3 Market size and forecast, by End User
      • 6.4.4.2 China
      • 6.4.4.2.1 Key market trends, growth factors and opportunities
      • 6.4.4.2.2 Market size and forecast, by Product
      • 6.4.4.2.3 Market size and forecast, by End User
      • 6.4.4.3 India
      • 6.4.4.3.1 Key market trends, growth factors and opportunities
      • 6.4.4.3.2 Market size and forecast, by Product
      • 6.4.4.3.3 Market size and forecast, by End User
      • 6.4.4.4 Australia
      • 6.4.4.4.1 Key market trends, growth factors and opportunities
      • 6.4.4.4.2 Market size and forecast, by Product
      • 6.4.4.4.3 Market size and forecast, by End User
      • 6.4.4.5 South Korea
      • 6.4.4.5.1 Key market trends, growth factors and opportunities
      • 6.4.4.5.2 Market size and forecast, by Product
      • 6.4.4.5.3 Market size and forecast, by End User
      • 6.4.4.6 Rest of Asia-Pacific
      • 6.4.4.6.1 Key market trends, growth factors and opportunities
      • 6.4.4.6.2 Market size and forecast, by Product
      • 6.4.4.6.3 Market size and forecast, by End User
  • 6.5 LAMEA
    • 6.5.1 Key trends and opportunities
    • 6.5.2 LAMEA Market size and forecast, by Product
    • 6.5.3 LAMEA Market size and forecast, by End User
    • 6.5.4 LAMEA Market size and forecast, by country
      • 6.5.4.1 Brazil
      • 6.5.4.1.1 Key market trends, growth factors and opportunities
      • 6.5.4.1.2 Market size and forecast, by Product
      • 6.5.4.1.3 Market size and forecast, by End User
      • 6.5.4.2 Saudi Arabia
      • 6.5.4.2.1 Key market trends, growth factors and opportunities
      • 6.5.4.2.2 Market size and forecast, by Product
      • 6.5.4.2.3 Market size and forecast, by End User
      • 6.5.4.3 South Africa
      • 6.5.4.3.1 Key market trends, growth factors and opportunities
      • 6.5.4.3.2 Market size and forecast, by Product
      • 6.5.4.3.3 Market size and forecast, by End User
      • 6.5.4.4 Rest of LAMEA
      • 6.5.4.4.1 Key market trends, growth factors and opportunities
      • 6.5.4.4.2 Market size and forecast, by Product
      • 6.5.4.4.3 Market size and forecast, by End User

CHAPTER 7: COMPANY LANDSCAPE

  • 7.1. Introduction
  • 7.2. Top winning strategies
  • 7.3. Product Mapping of Top 10 Player
  • 7.4. Competitive Dashboard
  • 7.5. Competitive Heatmap
  • 7.6. Key developments

CHAPTER 8: COMPANY PROFILES

  • 8.1 Johnson and Johnson (DePuy Synthes)
    • 8.1.1 Company overview
    • 8.1.2 Company snapshot
    • 8.1.3 Operating business segments
    • 8.1.4 Product portfolio
    • 8.1.5 Business performance
    • 8.1.6 Key strategic moves and developments
  • 8.2 Medtronic plc
    • 8.2.1 Company overview
    • 8.2.2 Company snapshot
    • 8.2.3 Operating business segments
    • 8.2.4 Product portfolio
    • 8.2.5 Business performance
    • 8.2.6 Key strategic moves and developments
  • 8.3 Globus Medical Inc
    • 8.3.1 Company overview
    • 8.3.2 Company snapshot
    • 8.3.3 Operating business segments
    • 8.3.4 Product portfolio
    • 8.3.5 Business performance
    • 8.3.6 Key strategic moves and developments
  • 8.4 Halma plc
    • 8.4.1 Company overview
    • 8.4.2 Company snapshot
    • 8.4.3 Operating business segments
    • 8.4.4 Product portfolio
    • 8.4.5 Business performance
    • 8.4.6 Key strategic moves and developments
  • 8.5 Zavation LLC
    • 8.5.1 Company overview
    • 8.5.2 Company snapshot
    • 8.5.3 Operating business segments
    • 8.5.4 Product portfolio
    • 8.5.5 Business performance
    • 8.5.6 Key strategic moves and developments
  • 8.6 BPB MEDICA - BIOPSYBELL
    • 8.6.1 Company overview
    • 8.6.2 Company snapshot
    • 8.6.3 Operating business segments
    • 8.6.4 Product portfolio
    • 8.6.5 Business performance
    • 8.6.6 Key strategic moves and developments
  • 8.7 Merit Medical Systems Inc.
    • 8.7.1 Company overview
    • 8.7.2 Company snapshot
    • 8.7.3 Operating business segments
    • 8.7.4 Product portfolio
    • 8.7.5 Business performance
    • 8.7.6 Key strategic moves and developments
  • 8.8 Seawon Meditech
    • 8.8.1 Company overview
    • 8.8.2 Company snapshot
    • 8.8.3 Operating business segments
    • 8.8.4 Product portfolio
    • 8.8.5 Business performance
    • 8.8.6 Key strategic moves and developments
  • 8.9 Joimax GmbH
    • 8.9.1 Company overview
    • 8.9.2 Company snapshot
    • 8.9.3 Operating business segments
    • 8.9.4 Product portfolio
    • 8.9.5 Business performance
    • 8.9.6 Key strategic moves and developments
  • 8.10 Stryker Corporation
    • 8.10.1 Company overview
    • 8.10.2 Company snapshot
    • 8.10.3 Operating business segments
    • 8.10.4 Product portfolio
    • 8.10.5 Business performance
    • 8.10.6 Key strategic moves and developments

LIST OF TABLES

  • TABLE 1. GLOBAL VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 2. VERTEBROPLASTY AND KYPHOPLASTY MARKET FOR KYPHOPLASTY, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 3. VERTEBROPLASTY AND KYPHOPLASTY MARKET FOR KYPHOPLASTY, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 4. VERTEBROPLASTY AND KYPHOPLASTY MARKET FOR VERTEBROPLASTY, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 5. VERTEBROPLASTY AND KYPHOPLASTY MARKET FOR VERTEBROPLASTY, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 6. GLOBAL VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 7. VERTEBROPLASTY AND KYPHOPLASTY MARKET FOR HOSPITALS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 8. VERTEBROPLASTY AND KYPHOPLASTY MARKET FOR HOSPITALS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 9. VERTEBROPLASTY AND KYPHOPLASTY MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 10. VERTEBROPLASTY AND KYPHOPLASTY MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 11. VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 12. NORTH AMERICA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 13. NORTH AMERICA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 14. NORTH AMERICA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 15. U.S. VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 16. U.S. VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 17. CANADA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 18. CANADA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 19. MEXICO VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 20. MEXICO VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 21. EUROPE VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 22. EUROPE VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 23. EUROPE VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 24. GERMANY VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 25. GERMANY VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 26. FRANCE VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 27. FRANCE VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 28. UK VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 29. UK VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 30. ITALY VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 31. ITALY VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 32. SPAIN VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 33. SPAIN VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 34. REST OF EUROPE VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 35. REST OF EUROPE VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 36. ASIA-PACIFIC VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 37. ASIA-PACIFIC VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 38. ASIA-PACIFIC VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 39. JAPAN VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 40. JAPAN VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 41. CHINA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 42. CHINA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 43. INDIA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 44. INDIA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 45. AUSTRALIA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 46. AUSTRALIA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 47. SOUTH KOREA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 48. SOUTH KOREA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 49. REST OF ASIA-PACIFIC VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 50. REST OF ASIA-PACIFIC VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 51. LAMEA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 52. LAMEA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 53. LAMEA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 54. BRAZIL VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 55. BRAZIL VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 56. SAUDI ARABIA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 57. SAUDI ARABIA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 58. SOUTH AFRICA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 59. SOUTH AFRICA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 60. REST OF LAMEA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 61. REST OF LAMEA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 62.JOHNSON AND JOHNSON (DEPUY SYNTHES): COMPANY SNAPSHOT
  • TABLE 63.JOHNSON AND JOHNSON (DEPUY SYNTHES): OPERATING SEGMENTS
  • TABLE 64.JOHNSON AND JOHNSON (DEPUY SYNTHES): PRODUCT PORTFOLIO
  • TABLE 65.JOHNSON AND JOHNSON (DEPUY SYNTHES): NET SALES
  • TABLE 66.JOHNSON AND JOHNSON (DEPUY SYNTHES): KEY STRATERGIES
  • TABLE 67.MEDTRONIC PLC: COMPANY SNAPSHOT
  • TABLE 68.MEDTRONIC PLC: OPERATING SEGMENTS
  • TABLE 69.MEDTRONIC PLC: PRODUCT PORTFOLIO
  • TABLE 70.MEDTRONIC PLC: NET SALES
  • TABLE 71.MEDTRONIC PLC: KEY STRATERGIES
  • TABLE 72.GLOBUS MEDICAL INC: COMPANY SNAPSHOT
  • TABLE 73.GLOBUS MEDICAL INC: OPERATING SEGMENTS
  • TABLE 74.GLOBUS MEDICAL INC: PRODUCT PORTFOLIO
  • TABLE 75.GLOBUS MEDICAL INC: NET SALES
  • TABLE 76.GLOBUS MEDICAL INC: KEY STRATERGIES
  • TABLE 77.HALMA PLC: COMPANY SNAPSHOT
  • TABLE 78.HALMA PLC: OPERATING SEGMENTS
  • TABLE 79.HALMA PLC: PRODUCT PORTFOLIO
  • TABLE 80.HALMA PLC: NET SALES
  • TABLE 81.HALMA PLC: KEY STRATERGIES
  • TABLE 82.ZAVATION LLC: COMPANY SNAPSHOT
  • TABLE 83.ZAVATION LLC: OPERATING SEGMENTS
  • TABLE 84.ZAVATION LLC: PRODUCT PORTFOLIO
  • TABLE 85.ZAVATION LLC: NET SALES
  • TABLE 86.ZAVATION LLC: KEY STRATERGIES
  • TABLE 87.BPB MEDICA - BIOPSYBELL: COMPANY SNAPSHOT
  • TABLE 88.BPB MEDICA - BIOPSYBELL: OPERATING SEGMENTS
  • TABLE 89.BPB MEDICA - BIOPSYBELL: PRODUCT PORTFOLIO
  • TABLE 90.BPB MEDICA - BIOPSYBELL: NET SALES
  • TABLE 91.BPB MEDICA - BIOPSYBELL: KEY STRATERGIES
  • TABLE 92.MERIT MEDICAL SYSTEMS INC.: COMPANY SNAPSHOT
  • TABLE 93.MERIT MEDICAL SYSTEMS INC.: OPERATING SEGMENTS
  • TABLE 94.MERIT MEDICAL SYSTEMS INC.: PRODUCT PORTFOLIO
  • TABLE 95.MERIT MEDICAL SYSTEMS INC.: NET SALES
  • TABLE 96.MERIT MEDICAL SYSTEMS INC.: KEY STRATERGIES
  • TABLE 97.SEAWON MEDITECH: COMPANY SNAPSHOT
  • TABLE 98.SEAWON MEDITECH: OPERATING SEGMENTS
  • TABLE 99.SEAWON MEDITECH: PRODUCT PORTFOLIO
  • TABLE 100.SEAWON MEDITECH: NET SALES
  • TABLE 101.SEAWON MEDITECH: KEY STRATERGIES
  • TABLE 102.JOIMAX GMBH: COMPANY SNAPSHOT
  • TABLE 103.JOIMAX GMBH: OPERATING SEGMENTS
  • TABLE 104.JOIMAX GMBH: PRODUCT PORTFOLIO
  • TABLE 105.JOIMAX GMBH: NET SALES
  • TABLE 106.JOIMAX GMBH: KEY STRATERGIES
  • TABLE 107.STRYKER CORPORATION: COMPANY SNAPSHOT
  • TABLE 108.STRYKER CORPORATION: OPERATING SEGMENTS
  • TABLE 109.STRYKER CORPORATION: PRODUCT PORTFOLIO
  • TABLE 110.STRYKER CORPORATION: NET SALES
  • TABLE 111.STRYKER CORPORATION: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 1.VERTEBROPLASTY AND KYPHOPLASTY MARKET SEGMENTATION
  • FIGURE 2.VERTEBROPLASTY AND KYPHOPLASTY MARKET,2021-2031
  • FIGURE 3.VERTEBROPLASTY AND KYPHOPLASTY MARKET,2021-2031
  • FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
  • FIGURE 5.PORTER FIVE-1
  • FIGURE 6.PORTER FIVE-2
  • FIGURE 7.PORTER FIVE-3
  • FIGURE 8.PORTER FIVE-4
  • FIGURE 9.PORTER FIVE-5
  • FIGURE 10.TOP PLAYER POSITIONING
  • FIGURE 11.VERTEBROPLASTY AND KYPHOPLASTY MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 12.VERTEBROPLASTY AND KYPHOPLASTY MARKET,BY PRODUCT,2021(%)
  • FIGURE 13.COMPARATIVE SHARE ANALYSIS OF KYPHOPLASTY VERTEBROPLASTY AND KYPHOPLASTY MARKET,2021-2031(%)
  • FIGURE 14.COMPARATIVE SHARE ANALYSIS OF VERTEBROPLASTY VERTEBROPLASTY AND KYPHOPLASTY MARKET,2021-2031(%)
  • FIGURE 15.VERTEBROPLASTY AND KYPHOPLASTY MARKET,BY END USER,2021(%)
  • FIGURE 16.COMPARATIVE SHARE ANALYSIS OF HOSPITALS VERTEBROPLASTY AND KYPHOPLASTY MARKET,2021-2031(%)
  • FIGURE 17.COMPARATIVE SHARE ANALYSIS OF AMBULATORY SURGICAL CENTERS VERTEBROPLASTY AND KYPHOPLASTY MARKET,2021-2031(%)
  • FIGURE 18.VERTEBROPLASTY AND KYPHOPLASTY MARKET BY REGION,2021
  • FIGURE 19.U.S. VERTEBROPLASTY AND KYPHOPLASTY MARKET,2021-2031($MILLION)
  • FIGURE 20.CANADA VERTEBROPLASTY AND KYPHOPLASTY MARKET,2021-2031($MILLION)
  • FIGURE 21.MEXICO VERTEBROPLASTY AND KYPHOPLASTY MARKET,2021-2031($MILLION)
  • FIGURE 22.GERMANY VERTEBROPLASTY AND KYPHOPLASTY MARKET,2021-2031($MILLION)
  • FIGURE 23.FRANCE VERTEBROPLASTY AND KYPHOPLASTY MARKET,2021-2031($MILLION)
  • FIGURE 24.UK VERTEBROPLASTY AND KYPHOPLASTY MARKET,2021-2031($MILLION)
  • FIGURE 25.ITALY VERTEBROPLASTY AND KYPHOPLASTY MARKET,2021-2031($MILLION)
  • FIGURE 26.SPAIN VERTEBROPLASTY AND KYPHOPLASTY MARKET,2021-2031($MILLION)
  • FIGURE 27.REST OF EUROPE VERTEBROPLASTY AND KYPHOPLASTY MARKET,2021-2031($MILLION)
  • FIGURE 28.JAPAN VERTEBROPLASTY AND KYPHOPLASTY MARKET,2021-2031($MILLION)
  • FIGURE 29.CHINA VERTEBROPLASTY AND KYPHOPLASTY MARKET,2021-2031($MILLION)
  • FIGURE 30.INDIA VERTEBROPLASTY AND KYPHOPLASTY MARKET,2021-2031($MILLION)
  • FIGURE 31.AUSTRALIA VERTEBROPLASTY AND KYPHOPLASTY MARKET,2021-2031($MILLION)
  • FIGURE 32.SOUTH KOREA VERTEBROPLASTY AND KYPHOPLASTY MARKET,2021-2031($MILLION)
  • FIGURE 33.REST OF ASIA-PACIFIC VERTEBROPLASTY AND KYPHOPLASTY MARKET,2021-2031($MILLION)
  • FIGURE 34.BRAZIL VERTEBROPLASTY AND KYPHOPLASTY MARKET,2021-2031($MILLION)
  • FIGURE 35.SAUDI ARABIA VERTEBROPLASTY AND KYPHOPLASTY MARKET,2021-2031($MILLION)
  • FIGURE 36.SOUTH AFRICA VERTEBROPLASTY AND KYPHOPLASTY MARKET,2021-2031($MILLION)
  • FIGURE 37.REST OF LAMEA VERTEBROPLASTY AND KYPHOPLASTY MARKET,2021-2031($MILLION)
  • FIGURE 38. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 39. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 40. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 41.PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 42.COMPETITIVE DASHBOARD
  • FIGURE 43.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
  • FIGURE 44.JOHNSON AND JOHNSON (DEPUY SYNTHES).: NET SALES ($MILLION)
  • FIGURE 45.MEDTRONIC PLC.: NET SALES ($MILLION)
  • FIGURE 46.GLOBUS MEDICAL INC.: NET SALES ($MILLION)
  • FIGURE 47.HALMA PLC.: NET SALES ($MILLION)
  • FIGURE 48.ZAVATION LLC.: NET SALES ($MILLION)
  • FIGURE 49.BPB MEDICA - BIOPSYBELL.: NET SALES ($MILLION)
  • FIGURE 50.MERIT MEDICAL SYSTEMS INC..: NET SALES ($MILLION)
  • FIGURE 51.SEAWON MEDITECH.: NET SALES ($MILLION)
  • FIGURE 52.JOIMAX GMBH.: NET SALES ($MILLION)
  • FIGURE 53.STRYKER CORPORATION.: NET SALES ($MILLION)